Sarah M. Weakley
- Molecular Biology
- Cancer Research top 5%
- Epidemiology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Surgery
- Co-authors
- Qizhi YaoChangyi ChenMd Saha JamaluddinPeter H. LinPanagiotis KougiasLidong ZhangYuqing ZhangHao Wang
- Topics
- MicroRNA in disease regulation (3 papers)Circular RNAs in diseases (3 papers)Aortic aneurysm repair treatments (2 papers)
- Partner nations
- United StatesThailand
In The Last Decade
Sarah M. Weakley
21 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 587
- Cancer Research 368
- Epidemiology 299
- Cardiology and Cardiovascular Medicine 208
- Surgery 171
Countries citing papers authored by Sarah M. Weakley
This map shows the geographic impact of Sarah M. Weakley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah M. Weakley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah M. Weakley more than expected).
Fields of papers citing papers by Sarah M. Weakley
This network shows the impact of papers produced by Sarah M. Weakley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah M. Weakley. The network helps show where Sarah M. Weakley may publish in the future.
Co-authorship network of co-authors of Sarah M. Weakley
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah M. Weakley. A scholar is included among the top collaborators of Sarah M. Weakley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah M. Weakley. Sarah M. Weakley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 42 | |
| 3 | 54 | |
| 4 | 390 | |
| 5 | 17 | |
| 6 | 12 | |
| 7 | 3 | |
| 8 | 53 | |
| 9 | 33 | |
| 10 | 10 | |
| 11 | 1 | |
| 12 | 10 | |
| 13 | 178 | |
| 14 | 70 | |
| 15 | 30 | |
| 16 | Arterial baroreceptors in the management of systemic hypertension. | 57 |
| 17 | Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. | 116 |
| 18 | 25 | |
| 19 | 33 | |
| 20 | 95 |
About Sarah M. Weakley
Sarah M. Weakley is a scholar working on Toxicology, Emergency Medical Services and Internal Medicine, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers) and Aortic aneurysm repair treatments (2 papers). The work is most often cited by research in Internal Medicine (97 citations), Cancer Research (368 citations) and Critical Care and Intensive Care Medicine (52 citations). Sarah M. Weakley has collaborated with scholars based in United States and Thailand. Frequent co-authors include Qizhi Yao, Changyi Chen, Md Saha Jamaluddin, Peter H. Lin, Panagiotis Kougias, Lidong Zhang, Yuqing Zhang, Hao Wang, Jun Jiang and Carlos F. Bechara. Their work appears in journals such as Journal of Nutrition, British Journal of Pharmacology and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.